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The addition of castanospermine (5-50 ,uM) to a culture medium of Caco-2 cells results in a specific suppres- 
sion of sucrase activity without modification of the biosynthesis of the enzyme. This effect is due to a direct 
inhibiting effect of castanospermine on Caco-2 sucrase activity. This inhibition is time-dependent (half-max- 
imum efficiency at 10 min for 100 nM), enhanced by preincubation (suggesting a strong interaction with 
the enzyme), dose-dependent (ED,, at 4 nM after 1 h preincubation period) and of the fully non-competitive 
type. The calculated K, (2.6 nM) suggests that castanospermine is the most potent inhibitor of sucrase so 
far reported. 
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1. INTRODUCTION 
Previous studies from this laboratory have 
shown that the modulation of the enterocytic dif- 
ferentiation, and more particularly of the expres- 
sion of sucrase in human colon cancer cells in 
culture such as HT-29 [1,2] and Caco-2 cells [3], 
was dependent on glucose metabolism, most likely 
through glucose-mediated modifications of protein 
glycosylation [4]. To investigate this relationship 
further we chose to study how castanospermine 
would affect the expression of sucrase in these 
cells. Castanospermine (1,6,7,%tetrahydroxyocta- 
hydroindolizine) (fig. I), an alkaloid isolated from 
OH 
Fig. 1. Structure of castanospermine (1,6,7,8_tetrahydro- 
xyoctahydroindolizine) from [5]. 
the seed of the Australian legume Castanosper- 
mum australiae [5] was chosen because it is known 
to interfere with the metabolism of glycogen [6] 
and to inhibit several glycosidases [7], including 
glucosidase I [8], one of the enzymes which control 
the processing of glycoproteins [9-111 (and 
presumably of brush border-associated hydrolases 
as they are known to be highly glycosylated 
glycoproteins [ 121). Our studies were conducted in 
the cell line Caco-2, as it is the cell line which 
shows the highest level of sucrase activity [3,13]. In 
the course of this study we observed that in Caco-2 
cells treated with castanospermine the activity of 
sucrase, but not of other hydrolases, was totally 
abolished without modifications of the biosyn- 
thesis of the enzyme. The results reported here 
show that this effect is due to a strong inhibiting 
effect of castanospermine on Caco-2 sucrase. The 
main characteristics of this inhibition are 
described. 
2. MATERIALS AND METHODS 
Caco-2 cells (obtained from J. Fogh, Memorial 
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Table 1 
Activities of brush border-associated hydrolases in control and castanospermine-treated 
Caco-2 cells 
Cell homogenate P2 fraction 
Control Castanospermine- Control Castanospermine- 
cells treated cells cells treated cells 
Sucrase 83.6 0 1034 0 
Aminopeptidase N 14.2 20.1 131.6 155.9 
Dipeptidyl peptidase IV 61.3 72.5 830.3 969.2 
Caco-2 cells were harvested on day 16 of the culture after a 48 h treatment with 25,~M 
castanospermine. Enzyme activities are expressed as mU/mg protein. Similar results were 
obtained in cells treated with castanospermine (5-50,uM) from day 1 to 16 
Sloan Kettering Center, Rye, NY) were cultured in 
plastic flasks as described in [3] and used between 
passages 148 and 161. Enzyme assays were per- 
formed on day 16 of the culture, i.e. when the cells 
are morphologically fully differentiated [3,13], the 
enzyme activities increase exponentially [3,13] and 
their synthesis is maximum (unpublished). Cell 
homogenates and brush border-enriched fractions 
(Pz) were prepared as described in [3] according to 
[14]. Sucrase (EC 3.2.1.48) activity was determined 
according to [15], aminopeptidase N (EC 3.4.11.2) 
according to [ 161 using L-alanine-p-nitroanilide as 
substrate, and dipeptidyl peptidase IV (EC 
3.4.14.5) according to [17] using 1.5 mM glycyl-l- 
proline-4-nitroanilide (at pH 8) as substrate. En- 
zyme activities are expressed as mU/mg protein, 1 
unit representing the hydrolysis of 1 pmol 
substrate per min under the experimental condi- 
tions. Glycogen was measured as in [3]. For 
sucrase-isomaltase biosynthesis studies the same 
methods as in [18] were applied to both the cell 
homogenate and the PZ fraction. Endo-@- 
acetylglucosaminidase H (Endo-H) [19] was ob- 
tained from Miles (France), castanospermine from 
Boehringer (Boehringer-Mannheim, FRG) and 
tunicamycin [20] from Calbiochem (Le VCsinet, 
France). 
3. RESULTS 
The addition of castanospermine to the culture 
medium of Caco-2 cells has no effect on glycogen 
content (not shown) and on the activities of 
aminopeptidase N and dipeptidyl peptidase IV, but 
cell homogenate P2 fraction kD 
-150 
B b c a b c-‘~ 
Fig.2. Autoradiographs of SDS-PAGE of 
immunoprecipitates of L-[%]methionine labeled 
sucrase-isomaltase, treated (+) or not (-) with Endo- 
H, from the cell homogenate and the brush border- 
enriched fraction (Pz) of Caco-2 cells. (a) Control cells, 
(b) cells treated for 48 h with 25 pM castanospermine, 
(c) cells treated for 48 h with 1OpM tunicamycin. 
Caco-2 cells were harvested on day 16 of the culture after 
a 3 h exposure to 500&i L-[35S]methionine. 
Immunoprecipitates were obtained with the use of 
monoclonal antibody HBB2/614/88 [18] (obtained from 
H.P. Hauri, Biocenter of the University of Basel, Basel, 
Switzerland). As described in [18] the upper band 
corresponds to the complex form of the enzyme and the 
lower band, sensitive to Endo-H treatment, to the high- 
mannose form. Under our experimental conditions 
castanospermine has no effect on the biosynthesis of the 
enzyme, in contrast to tunicamycin, an inhibitor of the 
first step of the N-core glycosylation [20] which has a 
strong inhibiting effect on the biosynthesis of the 
enzyme. 
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results in a total absence of activity of sucrase 
(table 1). The concomitant absence of effect of 
~astanospermin~ on the biosynthesis of the enzyme 
(fig.2) therefore suggested that the absence of 
sucrase activity was most likely the result of a 
direct inhibiting effect of the drug on Caco-2 
sucrase. 
This inhibition was investigated, using Caco-2 
brush border-enriched fractions as a source for 
sucrase. As shown in fig.3 the inhibiting effect is 
time-dependent with, for 100 nM, a half- 
maximum effect at 10 min. This effect also 
depends on the time of preincubation (fig.4) sug- 
gesting that the drug has a strong interaction with 
sucrase. This strong interaction is further sup- 
ported by the dose-response curves obtained with 
or without a 1 h preincubation (fig.51 which show 
that the EDK, decreases from 60 nM in non- 
preincubated samples to 4 nM in preincubated 
samples. It shouid also be noted that the slope of 
the curve obtained with preincubation is sharper 
60 90 min. 
incubation time 
Fig.3. Time course of sucrase and castanospermine 
inhibition. Pz fraction of control I6-day-old Caco-2 cells 
was used as a source for sucrase. Each value corresponds 
to 25 fig protein incubated in the absence (A) or presence 
(III) of 100 nM castanospermine. 
100 
30 60 90 120 min. 
preincubation time 
Fig.4. Effect of preincubation with castanospermine on 
the inhibition of Caco-2 sucrase activity. For each point 
25 pg protein were used. Sucrose was added to the assay 
at the indicated time of preincubation with 10 nM (m) 
and 100 nM (0) castanospermine. The enzyme assay 
was performed within 30 min (steady-state velocity). For 
each point results are expressed as percent of the 
corresponding control sample {without castanosper- 
mine). 
than in non-preincubated samples (figS), also in- 
dicating a strong interaction of castanospermine 
with sucrase. The Lineweaver-Burk plots derived 
from measurements of sucrase activities in extracts 
preincubated with increasing concentrations of 
castanospermine are reported in fig.6; this 
representation shows that the inhibition is of the 
fully non-competitive type and further indicates 
that the apparent Km of Caco-2 sucrase for 
sucrose, which has not been reported before, is 
9 mM. This fully non-competitive inhibition was 
confirmed by using the Henderson representation 
1211 (fig.7) which is more adapted to the very low 
concentrations of the inhibitor and further allows 
the calculation of the Ki value of the drug for 
sucrase (calculated Ki = 2.6 nM). 
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Fig.5. Dose-response curves of inhibition of sucrase 
activity by castanospermine without (0) or with (0) a 
1 h preincubation. Experimental conditions as in fig.4. 
Fig.6. Effect of sucrose (s) concentration on the 
inhibition of sucrase activity (v) by castanospermine. 
Assays were performed in the absence (0) or after a 1 h 
preincubation with 5 nM (o), 10 nM (0) and 50 nM 
(A) castanospermine. Results are plotted according to 
Lineweaver-Burk. 
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Fig.7. Henderson plot of the inhibition of Caco-2 
sucrase by castanospermine: i”, concentrations of 
castanospermine; v, and v,,, the velocities of the reaction 
in the presence or absence of castanospermine, 
respectively. The concentrations of substrate (sucrose, in 
mM) were: 2.8 (o), 11.2 (A), 28 (A), 56 (m) and 112 
(II). Inset: the slopes of the primary plots were replotted 
against the concentration of sucrose (s); the K, value is 
given by the intercept of this secondary plot with the 
slope axis. 
4. DISCUSSION 
The main conclusion to be drawn from this work 
is that castanospermine is a strong inhibitor of 
sucrase activity. As to the initial purpose of this 
work, which was to investigate whether 
castanospermine could modify the expression of 
brush border hydrolases in Caco-2 cells in culture 
via 2 of its known effects, i.e. modifications of 
glycogen metabolism [6] and inhibition of 
glucosidase I [8], it was observed that, under our 
experimental conditions, the drug had no effect on 
either glycogen or the biosynthesis of sucrase. 
The inhibiting effect of castanospermine, which 
was suggested from the specific absence of sucrase 
activity in cells grown in the presence of the drug, 
was confirmed by direct inhibition studies. From 
these studies it can be concluded that castanosper- 
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mine acts through a fully non-competitive 
mechanism, by contrast with other drugs known to 
inhibit sucrase activity such as nojirimycin, deox- 
ynojirimycin and acarbose [22]. This non- 
competitive characteristic of inhibition by 
castanospermine suggests that it could be a useful 
tool to study the relationship between the total 
splitting activity and the transglucosidation activi- 
ty of sucrase [23,24]. Comparison of our results 
(Ki = 2.6 nM, fig.7) with those reported for other 
inhibitors [22,23] suggests that castanospermine is
most likely the most potent inhibitor of sucrase so 
far described. Furthermore a strong interaction of 
the drug for sucrase is suggested by the 
preincubation-dependent increase of its inhibiting 
activity (figs 4,5) and by the differences in the 
slopes of the dose-response curves observed with 
or without preincubation. The fact that 
castanospermine inhibits sucrase activity is not 
totally surprising as it has been shown to inhibit 
the activity of some a-glucosidases [6,7]. 
These results imply that any study using 
castanospermine as an inhibitor of the process of 
glycosylation in intestinal cells should consider not 
only its strong inhibiting effect on sucrase activity, 
but also its strong interaction with the enzyme. 
REFERENCES 
111 
PI 
[31 
141 
[51 
Pinto, M., Appay, M.D., Simon-Assmann, P., 
Chevalier, G., Dracopoli, N., Fogh, J. and 
Zweibaum, A. (1982) Biol. Cell 44, 193-196. 
Zweibaum, A., Pinto, M., Chevalier, G., 
Dussaulx, E., Triadou, N., Lacroix, B., Haffen, 
K., Brun, J.L. and Rousset, M. (1985) J. Cell. 
Physiol. 122, 21-29. 
Rousset, M., Laburthe, M., Pinto, M., Chevalier, 
G., Rouyer-Fessard, C., Dussaulx, E., Trugnan, 
G., Boige, N., Brun, J.L. and Zweibaum, A. (1985) 
J. Cell. Physiol. 123, 377-385. 
Wice, B.M., Trugnan, G., Pinto, M., Rousset, M., 
Chevalier, G., Dussaulx, E., Lacroix, B. and 
Zweibaum, A. (1985) J. Biol. Chem. 260, 139-146. 
Hohenschutz, L.D., Bell, E.A., Jewess, P.J., 
Leworthy, D.P., Pryce, R.J., Arnold, E. and 
Clardy, J. (1981) Phytochemistry 20, 811-814. 
[6] Saul, R., Ghidoni, J.J., Molyneux, R.J. and 
Elbein, A.D. (1985) Proc. Natl. Acad. Sci. USA 82, 
93-97. 
[7] Saul, R., Chambers, J.P., Molyneux, R.J. and 
Elbein, A.D. (1983) Arch. Biochem. Biophys. 221, 
593-595. 
181 
191 
1101 
[Ill 
WI 
[I31 
v41 
1151 
iI61 
1171 
iI81 
iI91 
WI 
WI 
WI 
[231 
[241 
Pan, Y.T., Hori, H., Saul, R., Sanford, B.A., 
Molyneux, R.J. and Elbein, A.D. (1983) 
Biochemistry 22, 3975-3984. 
Grinna, L.S. and Robbins, P.W. (1979) J. Biol. 
Chem. 254, 8814-8818. 
Liu, T., Stetson, B., Turco, S. J., Hubbard, S.C. 
and Robbins, P.W. (1979) J. Biol. Chem. 254, 
4554-4559. 
Saunier, B., Kilker, R.D. jr, Tkacz, J.S., Quaroni, 
A. and Herscovics, A. (1982) J. Biol. Chem. 257, 
14155-14161. 
Kenny, A.J. and Maroux, S. (1982) Physiol. Rev. 
62, 91-128. 
Pinto, M., Robine-Leon, S., Appay, M.D., 
Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, 
B., Simon-Assmann, P., Haffen, K., Fogh, J. and 
Zweibaum, A. (1983) Biol. Cell 47, 323-330. 
Schmitz, J., Preiser, H., Maestracci, B., Ghosh, 
B.K., Cerda, J. J. and Crane, R.K. (1973) Biochim. 
Biophys. Acta 323, 98-112. 
Messer, M. and Dahlqvist, A. (1966) Anal. 
Biochem. 14, 376-392. 
Maroux, S., Louvard, D. and Baratti, J. (1973) 
Biochim. Biophys. Acta 321, 282-295. 
Nagatsu, T., Hino, M., Fuyamada, H., Hayakawa, 
T., Sakakibara, S., Nakagawa, Y. and Takemoto, 
T. (1976) Anal. Biochem. 74, 466-476. 
Hauri, H.P., Sterchi, E.E., Bienz, D., Fransen, J. 
and Marxer, A. (1985) J. Cell Biol. 101, 838-851. 
Tarentino, A.L. and Maley, F. (1974) J. Biol. 
Chem. 249, 811-817. 
Keenan, R.S., Hamill, R.L., Occolowitz, J.L. and 
Elbein, A.D. (1981) Biochemistry 20, 2186-2191. 
Henderson, P.J.F. (1972) Biochem. J. 127, 
321-333. 
Hanozet, G., Pircher, H.P., Vanni, P., Oesch, B. 
and Semenza, G. (1981) J. Biol. Chem. 256, 
3703-3711. 
Semenza, G. and Von Balthazar, A.K. (1974) Eur. 
J. Biochem. 41, 149-162. 
Cogoli, A. and Semenza, G. (1975) J. Biol. Chem. 
250, 7802-7809. 
32 
